We collected information about Ksq Therapeutics Hours for you. Follow the liks to find out everything about Ksq Therapeutics Hours.
KSQ-4279 is a first-in-class small molecule inhibitor of USP1 and is currently in a Phase 1 clinical trial in patients with advanced solid tumors, both as a monotherapy and in combination. Because of its potential in patients with homologous repair deficiencies (HRD), across a range of cancers, we believe KSQ-4279 has the potential to become a ...
https://ksqtx.com/contact-us/
Get in touch. Address & Phone: 610 Main Street North 4th Floor Cambridge MA, 02139. Tel: 617-674-9150. Email: Information: [email protected] Open Positions: [email protected]
https://hoursfinder.com/k-hours/ksq-therapeutics-hours.html
Ksq Therapeutics Hours information. Accurate information about Ksq Therapeutics Hours.
https://ksqtx.com/people/
Micah Benson, PhD, Senior Vice President, Immunobiology. Micah Benson has more than 15 years of industry and academic experience as an expert immunologist and drug hunter. Prior to joining KSQ Therapeutics, Micah served as Head of Tolerance Therapeutics in the Immunology and Inflammation Research Unit at Pfizer, Inc.
https://ksqtx.com/current-openings/
At KSQ Therapeutics, we are always looking for strong leaders to join our team. Contact us about current job opportunities. A NOTE TO RECRUITERS. To be able to manage our flow of candidates we do not accept unsolicited resumes from any source other than directly from the candidates for current or future positions. Submission of unsolicited ...
https://ksqtx.com/news-events/
KSQ Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference. September 14, 2021 KSQ Therapeutics Announces First Patient Dosed in Phase 1 Study of KSQ-4279, a First-in-Class USP1 Inhibitor, in Patients with Advanced Solid Tumors. May 13, 2021 KSQ Therapeutics Appoints Chris Heberlig as Chief Financial Officer. March 10, 2021
https://www.flagshippioneering.com/companies/ksq-therapeutics/
KSQ Therapeutics is a privately-held drug discovery company pioneering precision functional genomics technology to systematically identify, at the whole genome-scale, functionally-validated, novel drug targets for the development of breakthrough medicines. The company has initially focused on the fields of immuno-oncology and precision targeted ...
https://finance.yahoo.com/news/ksq-therapeutics-takeda-enter-broad-120000946.html
About KSQ Therapeutics. ... Shares of software maker Autodesk Inc. fell more than 12% in after-hours trading as the company narrowed its revenue and profit guidance and lowered its billings ...
https://pitchbook.com/profiles/company/181972-72
KSQ Therapeutics General Information Description. Developer of transformative medicines created to systematically pinpoint the optimal nodal targets of disease with precision. The company's industrialized functional genomics engine utilizes a suite of proprietary CRISPR/Cas9 tools that identifies novel pathways and targets involved in oncology ...
https://www.ziprecruiter.com/c/KSQ-Therapeutics/Job/Senior-Manager-Manager-Lab-Operations/-in-Cambridge,MA?jid=ff188d5475e7a99a
KSQ is led by a team of accomplished industry experts in drug discovery and development. Position Summary: Lab Manager KSQ Therapeutics is seeking a highly motivated, experienced Senior Manager/Manager of Lab Operations to help manage daily lab operations in the highly dynamic environment of a fast-growing and successful biotech.
Searching for Ksq Therapeutics Hours?
You can just click the links above. The info is collected for you.
